John P. Isacson, Partner, Pepper Hamilton LLP to Speak at The Knowledge Group’s Obviousness-Type Double Patenting: Navigating the Ever-Evolving Landscape LIVE Webcast

Top Quote John P. Isacson, Partner, Pepper Hamilton LLP will speak at its webcast entitled, “Obviousness-Type Double Patenting: Navigating the Ever-Evolving Landscape” scheduled for October 1, 2019 from 12:00 pm to 2:00 pm ET. End Quote
  • (1888PressRelease) September 17, 2019 - The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that John P. Isacson, Partner, Pepper Hamilton LLP will speak at its webcast entitled, “Obviousness-Type Double Patenting: Navigating the Ever-Evolving Landscape.” This event is scheduled for October 1, 2019 from 12:00 pm to 2:00 pm ET.

    For further details, please visit:

    About John P. Isacson
    John P. Isacson is a partner in the Intellectual Property Department of Pepper Hamilton LLP. Mr. Isacson focuses on representing clients in the pharmaceutical, biotechnology, chemical and medical device industries in all patent-related matters. His clients include internationally recognized research and health care institutions, emerging ventures, investors and large public corporations. Mr. Isacson has particular experience in strategic counseling and patent portfolio management, infringement litigation, due diligence, inter partes and post-grant reviews, reexaminations, patent interferences, inventorship and ownership disputes, matters involving biosimilar products, and Hatch-Waxman issues. He is regularly involved in litigation, arbitrations and U.S. Patent and Trademark Office and International Trade Commission proceedings. He has also advised on related FDA matters for certain technologies. He can be reached at isacsonj ( @ ) pepperlaw dot com dot

    About Pepper Hamilton LLP
    Pepper Hamilton LLP counsels each client as if it were our only client. With more than 425 lawyers in 14 offices across the United States, we use the unique skills and talents of our people, the breadth of our practices, and the depth of our experience to deliver powerful solutions to clients’ legal and business issues. Our Intellectual Property Department helps our clients protect and commercialize their intellectual property assets while minimizing the risk of liability. We assist companies with the full gamut of intellectual property matters, including patents, copyrights, trademarks, trade secret protection, unfair competition, privacy, and technology-related transactions. We also recognize that IP is a vital part of any company’s asset portfolio, and, when conflicts arise, we work to efficiently resolve disputes through litigation or alternative methods.

    The emergence of new court rulings in the U.S. and Canada continues to shape the applicability and scope of the obviousness-type double patenting (ODP) doctrine, which is meant to prevent patentees from unjustly extending patent rights by owning multiple patents on the same invention. Recently, the U.S. Court of Appeals for the Federal Circuit issued two significant decisions - Novartis AG v. Ezra Ventures LLC and Novartis Pharmaceuticals Corp. v. Breckenridge Pharmaceutical Inc. - which provide guidance on when ODP does not invalidate patent term extensions (PTEs). In Canada, where there is no terminal disclaimer, upcoming changes to the Patent Rules will impact procedures commonly used to prevent double patenting.

    Counsel to patent applicants and owners should be in the know of the recent court rulings and other developments involving ODP to better manage potential threats and opportunities regarding patent term and validity.

    This LIVE Webcast produced by The Knowledge Group will provide patent practitioners with an in-depth analysis of the evolving ODP landscape in the USA and Canada. They will examine the implications of recent U.S. Court rulings in Ezra and Breckenridge and other ODP updates while offering insights on how to best protect a client’s interests from significant ODP issues in the U.S. and Canada.

    Some of the major topics that will be covered in this course are:
    • Recent Court Rulings:
    o Novartis AG v. Ezra Ventures LLC
    o Novartis Pharmaceuticals Corp. v. Breckenridge Pharmaceutical Inc.
    • Implications of Recent Trends and Developments
    • Managing Potential Threats and Opportunities
    • Best Practices and Strategies

    About The Knowledge Group
    The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit:

  • FB Icon Twitter Icon In-Icon
Contact Information